You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APGE Sale Disclosure
Henderson Michael Thomas · SEC Form 4 · Filed Jun 12, 2026
Sale
Calculated transaction value
$633.6K
Henderson Michael Thomas Chief Executive Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Jun 10, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed 2 days later
APGE daily price context
Close on/before transaction
$82.72
Jun 10, 2026
First close after public filing
$86.19
Jun 15, 2026
30-day return after filing
+55.26%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,654 shares @ $82.78
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-073567
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.67M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Sale | Jun 10, 2026 | $556.56K |
| Apogee Therapeutics, Inc. APGE Current | Sale | Jun 10, 2026 | $633.6K |
| Apogee Therapeutics, Inc. APGE | Sale | Jun 10, 2026 | $90.91K |
| Apogee Therapeutics, Inc. APGE | Sale | Jun 10, 2026 | $134.34K |
| Apogee Therapeutics, Inc. APGE | Sale | Jun 10, 2026 | $198.85K |
| Apogee Therapeutics, Inc. APGE | Sale | Jun 10, 2026 | $53.35K |